Skip to main content
. Author manuscript; available in PMC: 2024 Jul 27.
Published in final edited form as: Eur Respir J. 2023 Jul 27;62(1):2300190. doi: 10.1183/13993003.00190-2023

FIGURE 5.

FIGURE 5

a) Forest plot of association of baseline REVEAL 2.0 risk (on continuous scale, per three-point increment) with time to clinical worsening. b) Forest plot of the baseline REVEAL 2.0 risk (on continuous scale, per three-point increment) by treatment interaction terms and time to clinical worsening. Weights are from random-effects model. REVEAL 2.0: US Registry to Evaluate Early and Long-Term PAH Disease Management.